SCHEMBL9866491

SCHEMBL9866491

NNC(=O)C(=O)NC1CCCCC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.77
NPC1 O15118 5/20 0.77
RAB9A P51151 5/20 0.77
MAPT P10636 3/20 0.77
MAPK1 P28482 1/20 0.57
DUSP3 P51452 1/20 0.57
PTPN5 P54829 1/20 0.57
PTPN11 Q06124 1/20 0.57
EPHX1 P07099 6/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
CYP3A4 P08684 1/20 0.56
EPHX2 P34913 1/20 0.56
HTT P42858 1/20 0.55
GAA P10253 2/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 2/20 0.48
MMP2 P08253 3/20 0.47
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28051161 0.98 SMN1; SMN2 (0.74) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL9867091 0.98 SMN1; SMN2 (0.73) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL9867405 0.93 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL4427177 0.88 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL23736058 0.88 NPC1 (1.00) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL2377367 0.88 NPC1 (1.00) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL8165938 0.88 NPC1 (1.00) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL3076504 0.88 NPC1 (1.00) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL6850969 0.85 SMN1; SMN2 (0.94) SMN1; SMN2NPC1RAB9AMAPTMAPK1
SCHEMBL3076671 0.79 NPC1 (0.73) SMN1; SMN2NPC1RAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104936961-B The preparation method of (1S, 4S, 5S)-4-bromo-6-oxabicyclo [3.2.1] octyl-7-ketone 第三共株式会社 2016-10-26 CN claimed
CN-103214414-B The diamine derivative of opticity and manufacture method thereof SANKYO CO. (JP) 2016-02-17 CN disclosed
CN-103140466-B Compound oxygen radical of nitrogen is adopted to prepare the method for compound through the reaction of new sandmeyer type as catalysts DAIICHI SANKYO Co.,Ltd. (JP) 2016-02-17 CN disclosed
CN-105008325-A Processes for preparing optically active diamine derivatives DAIICHI SANKYO CO LTD 2015-10-28 CN disclosed
CN-104936961-A Method for producing (1S,4S,5S)-4-bromo-6- oxabicyclo[3.2.1]octane-7-one DAIICHI SANKYO CO LTD 2015-09-23 CN disclosed
CN-103080078-B Process for producing optically active diamine derivative salt DAIICHI SANKYO CO LTD 2015-02-11 CN disclosed
CN-104324015-A PHARMACEUTICAL COMPOSITION DAIICHI SANKYO CO LTD 2015-02-04 CN disclosed
US-5051517-A Reacting a chloroformidine hydrochloride with an oxamohydrazide, forming bonds between carbon and nitrogen and cyclization BAYER AKTIENGESELLSCHAFT (DE) 1991-09-24 US disclosed
EP-0126326-B1 PROCESS FOR PREPARING 1,2,4-TRIAZOLE-3-CARBOXAMIDES UBE INDUSTRIES, LTD. (JP) 1987-08-05 EP disclosed
US-4578479-A Process for preparing 1,2,4-triazole-3-carboxamides UBE INDUSTRIES, LTD. (JP) 1986-03-25 US disclosed
EP-0126326-A1 Process for preparing 1,2,4-triazole-3-carboxamides UBE INDUSTRIES, LTD. (JP) 1984-11-28 EP disclosed